Intense throat pain is a key symptom of COVID-19 variant NB.1.8.1, referred to as "razor blade throat." Here's what to know.

A nasal COVID-19 vaccine developed by US biotech CyanVac has produced encouraging results in an early trial, showing potential to offer broader immunity and easier delivery than current injections.

Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...

The global Vaccines Market is estimated to be valued at USD 54.50 billion in 2025 and is projected to reach USD 111.3 billion by 2035, registering a compound annual growth rate (CAGR) of 7.4% over the ...

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

The US Food and Drug Administration (FDA) has provided an update on the risk of myocarditis after receiving an mRNA COVID-19 ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The seven new members of the Advisory Committee on Immunization Practices revived a decades-old debate with a Thursday vote in favor of recommending seasonal flu vaccines — only if they're ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 ...

The global COVID-19 vaccine packaging and delivery devices market is anticipated to reach USD 1,261.7 million in 2025 and expand to USD 2,436.1 million by 2035, reflecting a CAGR of 6.8% over the ...